Published in Am J Gastroenterol on January 08, 2008
Adipocytokines and liver disease. J Gastroenterol (2008) 1.25
Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis. Mol Med (2011) 0.95
Metabolic alterations and hepatitis C: From bench to bedside. World J Gastroenterol (2016) 0.91
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3. Clin Gastroenterol Hepatol (2011) 0.91
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med (2013) 0.88
Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection. PLoS One (2011) 0.84
HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients. Int J Hepatol (2012) 0.77
Inverse Levels of Adiponectin in Type 1 and Type 2 Diabetes Are in Accordance with the State of Albuminuria. Int J Endocrinol (2015) 0.75
Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response? Int J Hepatol (2015) 0.75
Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35
Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med (2011) 2.72
Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med (2004) 1.89
Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int (2008) 1.76
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. J Hepatol (2011) 1.56
Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48
Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology (2002) 1.41
Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis (2013) 1.16
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents (2012) 1.16
Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun Rev (2011) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome. Int J Infect Dis (2008) 1.12
Use of TNFα antagonists in refractory AIH: revealing the unforeseen. J Hepatol (2013) 1.07
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta. Hepatology (2014) 1.04
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med (2009) 1.03
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis (2007) 1.02
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev (2011) 1.01
Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med (2007) 1.01
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Liver Int (2011) 0.99
Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes. Diabetes Res Clin Pract (2006) 0.97
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int (2007) 0.96
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int (2009) 0.96
Autoimmune thyroiditis associated with autoimmune hepatitis. Thyroid (2005) 0.95
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infect Dis (2012) 0.95
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis (2004) 0.94
Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol (2008) 0.94
Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus. Clin Biochem (2007) 0.93
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol (2007) 0.93
Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol (2010) 0.92
Salmonella enteritidis Infection Complicated by Acute Myocarditis: A Case Report and Review of the Literature. Cardiol Res Pract (2011) 0.92
Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev (2012) 0.92
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. Turk J Gastroenterol (2012) 0.92
The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds (2013) 0.91
Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol (2012) 0.91
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol (2006) 0.91
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases. J Clin Immunol (2008) 0.91
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology (2007) 0.90
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis. BMC Musculoskelet Disord (2007) 0.89
Primary biliary cirrhosis: family stories. Autoimmune Dis (2011) 0.89
Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production. J Autoimmun (2005) 0.89
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment. Antivir Ther (2011) 0.89
Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside. Clin Res Hepatol Gastroenterol (2011) 0.89
Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diagn Lab Immunol (2005) 0.88
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med (2013) 0.88
Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature. J Med Case Rep (2011) 0.88
Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma. Hepat Mon (2013) 0.88
HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece. J Clin Virol (2005) 0.87
Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series. Cases J (2009) 0.87
Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece. Eur J Intern Med (2008) 0.86
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta (2007) 0.86
Molecular diagnostics of primary biliary cirrhosis. Expert Opin Med Diagn (2008) 0.86
Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis (2010) 0.85
Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease. Clin Dev Immunol (2012) 0.85
Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity. Obes Surg (2013) 0.84
Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun (2005) 0.84
Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat. World J Hepatol (2013) 0.84
Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity (2013) 0.84
Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing (2011) 0.84
Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature. Liver Int (2007) 0.83
Entecavir monotherapy for lamivudine-refractory chronic hepatitis B. Expert Rev Anti Infect Ther (2008) 0.82
PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Dis Markers (2010) 0.82
Severe pharyngitis in stockbreeders: an unusual presentation of brucellosis. Occup Med (Lond) (2008) 0.82
IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Clin Chim Acta (2012) 0.82
Hepatitis B re-activation with rituximab therapy: treat the patient not the disease. Liver Int (2011) 0.82
Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis. J Hepatol (2006) 0.82
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol (2011) 0.81
p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmun Rev (2012) 0.81
The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol (2013) 0.81
Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol (2009) 0.81
p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity. Autoimmune Dis (2013) 0.81
Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study. World J Gastroenterol (2005) 0.81
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clin Chim Acta (2012) 0.81
Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev (2012) 0.81